T

Telesis Bio

118 employees

Telesis Bio is a biotech company that empowers researchers with the tools to secure design, code, and create synthetic DNA and mRNA.

Basic info

Industry

biotechnology research

Sectors

Bioinformatic services
Biotechnology
Protein engineering
Enzyme engineering
mRNA
Custom cloning
Gene synthesis
DNA libraries
T-cell therapy
Error-free clones
Health Care
Cancer research
Next-generation sequencing
Precision medicine
Archetype software
CAR-T
Reagents
Gibson Assembly HiFi kit
Antibody engineering
Plasmid preparation
Bioinformatics

Date founded

2013

Funding rounds raised

Total raised

$74M

from 3 investors over 3 rounds

T

Telesis Bio raised $74M on May 31, 2023

Investors: Novalis LifeSciences LLC, BroadOak Capital Partners and Northpond Ventures

FAQ